4102.TWO · YUNGZIP
Taiwan · RS rating 29 · As of 2026-10-08
| Price | 18.80 TWD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 35 / 33 / 37 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 23 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -55.6% |
| Sales growth Q/Q | +24.1% |
| Distance from 52-week high | +18.8% |
| Market cap (USD) | $24.5M |